Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors |
Paudel, Suresh
(College of Pharmacy, Chonnam National University)
Kim, Eunae (College of Pharmacy, Chosun University) Zhu, Anlin (College of Pharmacy, Chonnam National University) Acharya, Srijan (College of Pharmacy, Chonnam National University) Min, Xiao (College of Pharmacy, Chonnam National University) Cheon, Seung Hoon (College of Pharmacy, Chonnam National University) Kim, Kyeong-Man (College of Pharmacy, Chonnam National University) |
1 | Koyuncu, A., Ertekin, E., Yuksel, C., Aslantas Ertekin, B., Celebi, F., Binbay, Z. and Tukel, R. (2015) Predominantly inattentive type of ADHD is associated with social anxiety disorder. J. Atten. Disord. 19, 856-864. DOI |
2 | Paudel, S., Cao, Y., Guo, S., An, B., Kim, K. M. and Cheon, S. H. (2015) Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors. Bioorg. Med. Chem. 23, 6418-6426. DOI |
3 | ChemAxon (2014) MarvinSketch (version 6.2.2). Calculation module developed by ChemAxon. Available from: http://www.chemaxon.com/products/marvin/marvinsketch/. |
4 | Coleman, J. A., Green, E. M. and Gouaux, E. (2016) X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334-339. DOI |
5 | Cho, D., Zheng, M., Min, C., Ma, L., Kurose, H., Park, J. H. and Kim, K. M. (2010) Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors. Mol. Endocrinol. 24, 574-86. DOI |
6 | Culpepper, L., Muskin, P. R. and Stahl, S. M. (2015) Major depressive disorder: understanding the significance of residual symptoms and balancing efficacy with tolerability. Am. J. Med. 128, S1-S15. DOI |
7 | Furukawa, T. A., Salanti, G., Atkinson, L. Z., Leucht, S., Ruhe, H. G., Turner, E. H., Chaimani, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Suganuma, A., Watanabe, N., Stockton, S., Geddes, J. R. and Cipriani, A. (2016) Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open 6, e010919. DOI |
8 | Prins, J., Olivier, B. and Korte, S. M. (2011) Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin. Investig. Drugs 20, 1107-1130. DOI |
9 | Ramsay, R. R., Popovic-Nikolic, M. R., Nikolic, K., Uliassi, E. and Bolognesi, M. L. (2018) A perspective on multi-target drug discovery and design for complex diseases. Clin. Transl. Med. 7, 3. DOI |
10 | Belmaker, R. H. and Agam, G. (2008) Major depressive disorder. N. Engl. J. Med. 358, 55-68. DOI |
11 | Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E. and Simmerling, C. (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696-3713. DOI |
12 | Jakubovski, E., Varigonda, A. L., Freemantle, N., Taylor, M. J. and Bloch, M. H. (2016) Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am. J. Psychiatry 173, 174-183. DOI |
13 | Zheng, Y. Y., Guo, L., Zhen, X. C. and Li, J. Q. (2012) Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. Eur. J. Med. Chem. 54, 123-136. DOI |
14 | Nestler, E. J. and Carlezon, W. A., Jr. (2006) The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151-1159. DOI |
15 | Talevi, A. (2015) Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective. Front. Pharmacol. 6, 205. DOI |
16 | Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R. and Schwede, T. (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296-W303. DOI |
17 | Goodwin, G. M. (2015) The overlap between anxiety, depression, and obsessive-compulsive disorder. Dialogues Clin. Neurosci. 17, 249-60. DOI |
18 | Hepler, J. R. and Gilman, A. G. (1992) G proteins. Trends Biochem. Sci. 17, 383-387. DOI |
19 | Hirschfeld, R. M. (2000) History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry 61 Suppl 6, 4-6. |
20 | Kim, K. M., Valenzano, K. J., Robinson, S. R., Yao, W. D., Barak, L. S. and Caron, M. G. (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J. Biol. Chem. 276, 37409-37414. DOI |
21 | Masson, J., Sagne, C., Hamon, M. and El Mestikawy, S. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439-464. |
22 | Trott, O. and Olson, A. J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455-461. DOI |
23 | Zhang, X. and Kim, K. M. (2017) Multifactorial regulation of G protein-coupled receptor endocytosis. Biomol. Ther. (Seoul) 25, 26-43. DOI |
24 | Millan, M. J. (2006) Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110, 135-370. DOI |
25 | Paudel, S., Acharya, S., Yoon, G., Kim, K. M. and Cheon, S. H. (2017a) Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors. Bioorg. Med. Chem. 25, 2266-2276. DOI |
26 | Paudel, S., Min, X., Acharya, S., Khadka, D. B., Yoon, G., Kim, K. M. and Cheon, S. H. (2017b) Triple reuptake inhibitors: design, synthesis and structure-activity relationship of benzylpiperidinetetrazoles. Bioorg. Med. Chem. 25, 5278-5289. DOI |
27 | Sharma, H., Santra, S. and Dutta, A. (2015) Triple reuptake inhibitors as potential next-generation antidepressants: a new hope? Future Med. Chem. 7, 2385-2406. DOI |
28 | Torres, G. E., Yao, W. D., Mohn, A. R., Quan, H., Kim, K. M., Levey, A. I., Staudinger, J. and Caron, M. G. (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30, 121-134. DOI |
29 | Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. and Ferrin, T. E. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612. DOI |
30 | Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A. and Geddes, J. R. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357-1366. DOI |
31 | Trivedi, M. H. (2006) Major depressive disorder: remission of associated symptoms. J. Clin. Psychiatry 67 Suppl 6, 27-32. |
32 | Wang, K. H., Penmatsa, A. and Gouaux, E. (2015) Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322-327. DOI |